Cargando…
LB13. Candida auris in NYC: A Health System’s Experience Treating the Emerging Drug-Resistant Yeast
BACKGROUND: Candida auris is emerging multidrug-resistant yeast that can cause serious infections with published mortality rates as high as 60%. It was first recognized in 2009 and has been reported in over a dozen countries. The current United States outbreak was identified in 2016 with New York Ci...
Autores principales: | Mazo, Dana, Gottlieb, Lindsey, Schaefer, Sarah, Alexander, Kinta, Ehni, Jordan, Javaid, Waleed, Patel, Gopi, Aberg, Judith, Lorin, Scott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254832/ http://dx.doi.org/10.1093/ofid/ofy229.2187 |
Ejemplares similares
-
526. Significant Reduction of Hospital Onset Carbapenem-Resistant Enterobacteriaceae Utilizing Infection Prevention Strategies: It takes a Village!
por: Alexander, Kinta, et al.
Publicado: (2019) -
LB1578. Fully Automated Real-Time PCR for Detection of Candida auris
por: Jiang, Alice, et al.
Publicado: (2022) -
Molecular Detection of Candida auris Using DiaSorin Molecular Simplexa(®) Detection Kit: A Diagnostic Performance Evaluation
por: Ramírez, Juan David, et al.
Publicado: (2023) -
NO Candida auris: Nitric Oxide in Nanotherapeutics to Combat Emerging Fungal Pathogen Candida auris
por: Cleare, Levi G., et al.
Publicado: (2020) -
1152. Implementation of Enhanced Data Surveillance Methods to Reduce Catheter-Associated Urinary Tract Infections
por: Ehni, Jordan, et al.
Publicado: (2019)